PDL BioPharma to Participate in the 2019 Cantor Fitzgerald Global Healthcare Conference

September 26, 2019 |

1 min read

The conference is being held at the Intercontinental New York Barclay Hotel.

INCLINE VILLAGE, Nev., Sept. 26, 2019 /PRNewswire/ -- PDL BioPharma Inc. (“PDL” or the “Company”) (NASDAQ: PDLI) announces that Dominique Monnet, PDL’s president and chief executive officer, will present at the 2019 Cantor Fitzgerald Global Healthcare Conference on Friday, October 4, 2019, at 1:10 p.m. Eastern time (10:10 a.m. Pacific time). The conference is being held at the Intercontinental New York Barclay Hotel.

To access the live and subsequently archived webcast of the presentation, visit the Company’s website at https://www.pdl.com/, go to the Investor Relations section and select “Events & Presentations.” Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary. The archived webcast will be available for at least seven days following the presentation.

About PDL BioPharma, Inc.
PDL’s mission is to improve the lives of patients and create value for our shareholders and our people by applying our capital and expertise for the successful development and commercialization of innovative therapeutics by our partner companies. We deliver on our mission by entering into strategic transactions involving innovative late clinical-stage or early commercial-stage therapeutics with attractive revenue growth potential. For more information please visit www.pdl.com.

NOTE: PDL, PDL BioPharma, the PDL logo and associated logos and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary to, PDL BioPharma, Inc. which reserves all rights therein.

PDL BioPharma, Inc. (PRNewsFoto/PDL BioPharma, Inc.)